All Articles
Governance insights and analysis for biopharma board members.
Board Dynamics & Effectiveness4 min read
Managing the Tension Between Investor and Independent Directors
The tension between investor and independent directors is the most common source of board dysfunction in biopharma. It doesn't have to be.
|Lawrence Fine
Capital & Strategic Transactions3 min read
Board Governance During Fundraising
Fundraising is when governance is most tested and most needed. Conflicts multiply, timelines compress, and the board's fiduciary duties become acutely complex.
|Lawrence Fine
Clinical-Stage Decision Making3 min read
The Board's Role in Trial Go/No-Go Decisions
Trial go/no-go decisions are among the most consequential a biopharma board will face. Getting the governance right means knowing where the board's role ends and management's begins.
|Lawrence Fine
Governance Fundamentals3 min read
Why Biopharma Board Governance Is Fundamentally Different
Corporate governance principles were designed for companies with revenue, customers, and operating history. Biopharma boards face a fundamentally different reality.
|Lawrence Fine